Initial Results of a Phase 2 Trial of Stereotactic Body Radiation Therapy, Hormone/Androgen Deprivation Therapy and Radium 223 Dichloride for Oligometastatic Castrate Sensitive Prostate Cancer (SHARP).

Autor:	Dandapani, S.V.1 (AUTHOR), Hao, C.1 (AUTHOR), Ladbury, C.J.1 (AUTHOR), Wong, J.Y.C.1 (AUTHOR), Li, Y.R.1 (AUTHOR), Liu, J.R.1 (AUTHOR), Glaser, S.M.1 (AUTHOR), Lee, P.2 (AUTHOR), Mandelin, P.M.3 (AUTHOR), Pal, S.K.4 (AUTHOR), Alcantara, M.3 (AUTHOR), Kortylewski, M.5 (AUTHOR), Frankel, P.6 (AUTHOR), Ruel, C.3 (AUTHOR), Chehrazi-Raffle, A.3 (AUTHOR), Lyou, Y.3 (AUTHOR), Liu, J.7 (AUTHOR), Simpson, J.7 (AUTHOR), Dorff, T.B.4 (AUTHOR), Twardowski, P.8 (AUTHOR)
Zdroj:	International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS147-S148. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu